PHARMEXA
More informations about "Pharmexa"
Pharmexa 2025 Company Profile: Valuation, Investors ... - PitchBook
Pharmexa General Information Description. Manufacturer of cancer vaccines. The company develops cancer vaccines and T cell epitope based immunotherapies for cancer and infectious …See details»
Pharmexa A/S - Hørsholm, Denmark - bionity.com
Pharmexa A/S is a leading company in the field of active immunotherapy and vaccines for the treatment of cancer, serious chronic and infectious diseases. Pharmexa's proprietary …See details»
Pharmexa - Crunchbase Company Profile & Funding
Organization. Pharmexa . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. Vaccine research and development company, based in …See details»
Pharmexa A/S (CSE: PHARMX) - Life-Sciences-Europe.com
May 29, 2001 BIO (US) (Biotechnology Innovation Organization, formerly Biotechnology Industry Organization) EuropaBio aisbl – the European Association of Bioindustries; BioIndustry …See details»
Pharmexa Focuses and Adjusts the Organization - GlobeNewswire
Jan 29, 2003 These adjustments also lead to changes in Pharmexa's organization. Pharmexa today announces a lay-off of 31 employees, which together with a number of other changes …See details»
Pharmexa-Epimmune 2025 Company Profile: Valuation, Investors ...
Pharmexa-Epimmune General Information Description. Developer of cancer vaccines. The company engages in the manufacture of pharmaceuticals used in the treatment of cancer, …See details»
Pharmexa Limited
Pharmexa is a kiwi owned company and has been around since 1971 and we still play an important part in our country’s economy. Pharmexa is committed to delivering the highest quality, most reliable skin protection products in the …See details»
Organization | Pharmexa A/S - Purdue University
Pharmexa A/S Report issue. For profit Phase 1 Phase 3. Founded: Horsholm Denmark ... Organization Overview. First Clinical Trial. 2006 NCT00358566. First Marketed Drug. None …See details»
Pharmexa A/S:Company Profile & Technical Research,Competitor …
Oct 21, 2023 Pharmexa A/S is a company that provides Botanical drug, Herb, Breast cancer and more. Pharmexa A/S is headquartered in Denmark . Pharmexa A/S has a total of 447 patents . …See details»
Pharmexa (Group) - life-sciences-europe.com
Life Sciences Business Intelligence Web Portal for European countriesSee details»
Pharmexa A/S - Drug pipelines, Patents, Clinical trials - Synapse
Explore Pharmexa A/S with its drug pipeline, therapeutic area, technology platform, 6 clinical trials, and 1 literature, Drug:Tertomotide hydrochloride, MVA-BN-HER2, PX-1031(Pharmexa …See details»
PHARMEXA LIMITED Company Profile - Dun & Bradstreet
Pharmexa limited. d&b business directory home / business directory / retail trade / sporting goods, hobby, musical instrument, book, and miscellaneous retailers / other miscellaneous retailers / …See details»
Affitech acquires full rights to dibody technology from Pharmexa
Nov 5, 2008 Antibody specialist Affitech AB acquired the full rights to diabody technology originally owned by Pharmexa A/S, the Danish immunotherapy and vaccine company. No …See details»
Pharmexa to explore strategic alternatives | Reuters
Danish biotech firm Pharmexa <PHARMX.CO> said on Monday it would cut costs, prioritise its projects and explore its strategic alternatives with HSBC <HSBA.L> as its financial adviser to …See details»
PHARMEXA INC San Diego CA, 92121 - Company Profile - Cortera
Free Business profile for PHARMEXA INC at 5820 Nancy Ridge Dr, San Diego, CA, 92121-2843, US. This business can be reached at (858) 860-2500See details»
Pharmexa-Epimmune, Inc. - Drug pipelines, Patents, Clinical trials ...
A Phase 1 Safety and Immunogenicity Study of the Pharmexa-Epimmune HIV-1 CTL Epitope-Based DNA Vaccine (EP HIV-1090) Administered Using a Biojector 2000 Needle Free …See details»
Pharmexa sammenlægges med norske Affitech - Børsen
Pharmexa forventer at indkalde til ekstraordinær generalforsamling i marts/april med henblik på godkendelse af transaktionen, forklares det. "Pharmexa har haft et antal fejlslagne projekter i …See details»
Pharmexa A/S (Pharmexa A/S) - 药物管线_专利_临床试验_投融营 …
了解Pharmexa A/S (Pharmexa A/S)公司的药物管线，治疗领域，技术平台，以及它的6项临床试验和1篇文献，药物:特托莫肽盐酸盐，MVA-BN-HER2，PX-1031(Pharmexa A/S)。See details»
Pharmexa-Epimmune, Inc. (Pharmexa-Epimmune, Inc.) - 药物管线_ …
项与 Pharmexa-Epimmune, Inc. 相关的文献（医药） 2012-05-01 · Clinical and Vaccine Immunology DNA and Modified Vaccinia Virus Ankara Vaccines Encoding Multiple Cytotoxic …See details»
Pharmexa - schueco.com
High-performance mullion/transom façade with 50 mm face width – the basis for a variety of solutions. The Schüco FWS 50 façade system is an impressive basic system for façades and …See details»